Akanda Wraps Up $5M Private Placement, Will Distribute Cannim Cannabis Products Across UK Via CanMart
Akanda Wraps Up $5M Private Placement, Will Distribute Cannim Cannabis Products Across UK Via CanMart
Akanda Corp. announced on Wednesday that it has secured $5.31 million in financing through a private placement of its securities.
阿肯达公司(Akanda Corp.)周三宣布，它已经通过私募其证券获得531万美元的融资。
The London-based company closed the transaction and plans to use the net proceeds for working capital and general corporate purposes.
这家总部位于伦敦的公司完成了交易，并计划将净收益用于营运资金和一般公司用途。
Tej Virk, Akanda’s CEO and director said the financing provides essential capital to accelerate its plans to build its seat-to-patient business model.
Tej Virk，Akanda首席执行官兼董事表示，这笔融资为其加快建立座位到患者商业模式的计划提供了必要的资金。
“In the UK, we are building out our network of pharmacies, clinicians, and other innovative channels as we seek to democratize access to medical cannabis for patients throughout the United Kingdom,” Virk said. “In Lesotho, we are putting the finishing touches on a cultivation expansion project which is expected to be completed over the coming months.“
Virk说：“在英国，我们正在建立我们的药房、临床医生和其他创新渠道的网络，因为我们寻求使英国各地的患者获得医用大麻的渠道民主化。”“在莱索托，我们正在收尾一个种植扩建项目，预计将在未来几个月内完成。”
Boustead Securities, LLC served as exclusive placement agent for the Akanda private placement offering and has accepted warrants as partial remuneration in addition to a cash fee.
Boustead Securities，LLC担任Akanda私募发售的独家配售代理，并接受认股权证作为现金费用以外的部分报酬。
The move follows the closing of the share purchase transaction with Halo Collective Inc. (NEO: HALO) (OTCQB:HCANF), under which each of Bophelo Bio Science & Wellness Pty. Ltd. and CanMart Ltd. were acquired by Akanda, thus creating a new company focused on medical cannabis for international markets.
这个这一举措是在完成与Halo Collective Inc.的股票购买交易之后进行的。(NEO：HALO)(OTCQB：HCANF)，博菲罗生物科学与健康私人有限公司(Bophelo Bio Science&Wellness Pty)。有限公司和CanMart有限公司被阿肯达收购，从而创建了一家专注于面向国际市场的医用大麻的新公司。
Akanda’s CanMart To Distribute Cannim Cannabis Products Across Britain
阿肯达的CanMart将在英国分销大麻产品
In the meantime, on Tuesday, Akanda revealed that its wholly-owned subsidiary, CanMart Ltd., had entered into a distribution deal with Australia-based Cannim to bring the award-winning Lumir range of medical cannabis products to UK patients.
与此同时，阿肯达周二透露，其全资子公司、CanMart Ltd.、已经签订了一份与总部位于澳大利亚的Cannim达成分销协议将获奖的Lumir医用大麻产品系列带给英国患者。
Under the terms of the five-year agreement, CanMart will import and distribute Cannim’s full-spectrum cannabis oil products.
根据这份为期五年的协议条款，CanMart将进口和分销Cannim的全光谱大麻油产品。
Virk said that UK-based patients will now have access to “Cannim’s high-quality Jamaica-grown medical cannabis products for the first time,” calling the deal “another step” in the company’s “effort to establish an international supply chain based on a unique ‘open marketplace’ model that provides patients with maximum choice.”
Virk说，英国的患者现在可以第一次接触到Cannim的高质量牙买加种植的医用大麻产品，称这笔交易是该公司“基于独特的‘开放市场’模式建立国际供应链，为患者提供最大选择的努力的又一步”。
Stuart Marsh, Cannim’s chief commercial officer, agreed that the company's expansion is essential.
斯图尔特·马什，坎尼姆的首席商务官他们一致认为，公司的扩张至关重要。
“The UK is an important link in a string of new market entries obtained by Cannim in recent months, including securing access to the burgeoning German medicinal cannabis market in August, launching into Australia under the Hummingbud brand in September,” Marsh said.
马什说：“英国是Cannim近几个月来获得的一系列新市场进入中的重要一环，包括8月份进入蓬勃发展的德国医用大麻市场，9月份以Hummingbud品牌进入澳大利亚。”
Photo: Courtesy of Matteo Paganelli on Unsplash
图片：由Matteo Paganelli在Unspash上提供
译文内容由第三方软件翻译。